BioVisioN AG receives United States Patent for Peptide-Biomarker Discovery and Identification Technology
The patent office of the United States of America has granted the patent for BioVisioN's core technology, the "Differential Peptide Display"® (DPD), for the discovery and identification of peptide biomarkers. The methods allow the analysis and comparison of peptides in any biological sample and represent the most important component of the company's Peptidomics® technologies. Peptides are being valued and intensely researched by the pharmaceutical industry because of their potential as biomarkers and drugs. BioVisioN has already received patents for the DPD-Technology in Europe and other important pharmaceutical markets.
Using mass spectrometry BioVisioN's Differential Peptide Display analyses virtual every peptide in clinical samples like blood or urine, offering sensitivities down to picograms per milliliter. Using bioinformatic software tools developed in-house, the quantitative comparison of hundreds of samples is possible, making the technology suitable for biomarker discovery within clinical trials. The comparison of samples from e.g. patients and healthy controls shows up quantitative differences in peptide content characteristic of the disease studied. This provides for the identification of new diagnostic markers or biomarkers and also therapeutic leads and targets.
Organizations
Other news from the department research and development
These products might interest you

Limsophy by AAC Infotray
Optimise your laboratory processes with Limsophy LIMS
Seamless integration and process optimisation in laboratory data management

ERP-Software GUS-OS Suite by GUS
Holistic ERP solution for companies in the process industry
Integrate all departments for seamless collaboration

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
See the theme worlds for related content
Topic World Mass Spectrometry
Mass spectrometry enables us to detect and identify molecules and reveal their structure. Whether in chemistry, biochemistry or forensics - mass spectrometry opens up unexpected insights into the composition of our world. Immerse yourself in the fascinating world of mass spectrometry!

Topic World Mass Spectrometry
Mass spectrometry enables us to detect and identify molecules and reveal their structure. Whether in chemistry, biochemistry or forensics - mass spectrometry opens up unexpected insights into the composition of our world. Immerse yourself in the fascinating world of mass spectrometry!